1994
DOI: 10.1046/j.1537-2995.1994.34694295068.x
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of a transfusion preparation of newly formed red cells and standard washed red cell transfusions in patients with homozygous β‐ thalassemia

Abstract: These data demonstrate that extension of the transfusion interval, and reduction in transfused iron, may be achieved in thalassemic patients by use of the Neocel system. These benefits are achieved, however, with substantial increases in donor exposure and in component preparation costs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
22
0

Year Published

1998
1998
2016
2016

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 29 publications
(26 citation statements)
references
References 16 publications
4
22
0
Order By: Relevance
“…41-48 days (average 45 days) over control group patients, in which it was 21-27 days (average 24.5 days). It is nearly the same as observed by Propper et al 1980 [16] and Collin A F et al 1994 [21] , 43 +/-4.5 days and 35-44.5 days respectively in their studies of neocytes transfusion.…”
Section: Discussionsupporting
confidence: 89%
See 3 more Smart Citations
“…41-48 days (average 45 days) over control group patients, in which it was 21-27 days (average 24.5 days). It is nearly the same as observed by Propper et al 1980 [16] and Collin A F et al 1994 [21] , 43 +/-4.5 days and 35-44.5 days respectively in their studies of neocytes transfusion.…”
Section: Discussionsupporting
confidence: 89%
“…As the transfusion intervals increased and numbers of transfusion (7 versus 12) decreased in study group than control group, so the observation is in accordance with previous study like Bertholey F et al 1990 [17] , Montoya AF et al 1993 [18] , Spanos T et al 1996 [19] and Collin A F et al 1994. [21] Extension of transfusion intervals observed in our study group patients was significant i.e. 41-48 days (average 45 days) over control group patients, in which it was 21-27 days (average 24.5 days).…”
Section: Discussionmentioning
confidence: 43%
See 2 more Smart Citations
“…They occur due to decreased/absent synthesis of β globulin chains [1]. β-thalassemia major is an autosomal recessive genetic disorder, which is clinically; the most severe form and the affected child is dependent on regular blood transfusion for survival [2]. The current management of β-thalassemia major patient is based on regular transfusion of packed red cells and effective chelating therapy [3][4][5][6].…”
Section: Introductionmentioning
confidence: 99%